Fred Hutchinson Cancer Research Center
Cell death, innate signaling, and repair: Tale of a “dead-man’s switch” orchestrating tissue regeneration
April 20, 2020
Dr. Dudakov graduated with a PhD in Immunology and Stem Cell Biology from Monash University in Australia, and completed a postdoctoral fellowship in the Immunology Program at Memorial Sloan Kettering Cancer Center in New York. In 2016 Dr. Dudakov moved to Seattle to establish his lab in at the Fred Hutch. The Dudakov lab is working to understand the mechanisms underlying natural thymic regeneration so that new therapies can be developed to enhance T cell immunity. Targeted thymic regeneration could be extremely valuable not only for patients who undergo thymus-damaging radiation and/or chemotherapy.
thymus, hematopoietic stem cells, T cell function, regenerative medicine
Walk On Music
- The Cat Empire – Wandering
- Frank Zappa and the Mothers of Invention – You’re Probably Wondering Why I’m Here